BTL’s EMSCULPT NEO Powers Astronaut Training in Hungary for International Space Missions
BTL, a global leader in medical technology, has made significant strides in preparing astronauts for space missions using its flagship device, EMSCULPT NEO. This innovative machine has been incorporated into the intensive pre-flight training program of Hungarian astronaut Tibor Kapu, who is set to embark on a mission to the International Space Station (ISS).
EMSCULPT NEO: Key to Astronaut Training
In collaboration with the HUNOR (Hungarian To Orbit) program, EMSCULPT NEO plays a crucial role in enhancing the physical conditioning of astronauts. Research indicates that astronauts can lose up to 30% of their muscle mass while in orbit, depending on mission duration. Dr. Nóra Sydó, a cardiologist and sports medicine expert from Semmelweis University in Budapest, leads the astronaut training team and has highlighted the importance of EMSCULPT NEO in maximizing muscle performance and recovery.
Comprehensive Training Protocol
The training program incorporates EMSCULPT NEO as part of a holistic conditioning protocol focused on improving:
- Endurance
- Strength
- Balance
- Recovery
Dr. Sydó noted, “This technology has provided results that surpass those of traditional training methods.” Medical assessments revealed notable muscle hypertrophy, improved body composition, and enhanced cardiopulmonary capacity as key outcomes of using EMSCULPT NEO.
Innovations and Broader Applications
EMSCULPT NEO employs patented muscle stimulation technology and is widely utilized across various medical specialties, including aesthetics, functional medicine, and rehabilitation. “We take pride in our contribution to improving lives through innovation,” stated Tomas Schwarz, CEO of BTL Enterprise Group. He noted that the application of their technologies in space exploration underscores their positive societal impact.
While aiding in astronaut training marks a remarkable achievement, the benefits of EMSCULPT NEO extend beyond space missions. Dr. Sydó emphasized its potential for use among diverse populations, whether elite athletes or patients experiencing muscle loss, marking it as an effective, safe, and non-invasive solution for preserving and enhancing muscle function.
About BTL
Founded in 1993, BTL is renowned for its medical devices and innovative solutions across a range of fields, including dermatology, orthopedic care, and rehabilitation. With over 200 patents and a robust team of more than 600 internal engineers, BTL leverages technology and science to advance medical treatments. Their product portfolio features EMSCULPT NEO®, EMFACE®, and more, as they continue to lead in the medical technology arena.
